trial
as of 2026-07-01Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia
NCTId NCT00575848
at a glance
Phase 1 · Terminated
Enrollment 16 (estimated)
Sponsored by North Suffolk Mental Health Association
Primary completion 2008-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Terminated
Enrollment
16 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2007-12
Primary completion
2008-10
Eligibility
MALE · 18 Years · 65 Years
Interventions & indications
Sponsors
North Suffolk Mental Health AssociationLead Sponsor
Mclean HospitalCollaborator
Investigators
2
A. Eden Evins, M.D., M.P.H.Principal Investigator
Andrew Prescot, Ph.D.Principal Investigator
Sites
2 total
Belmont, United StatesBoston, United States
Facts & assertions
4 sourced
Enrollment
16
Phase
PHASE1
Primary Completion Date
2008-10
Status
TERMINATED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person